Society for Endocrinology - a world-leading authority on hormones

Clinical practice

Society position statements

Responses to important advances or changes in treatments, or topical issues in the field of endocrinology.


October 2018


Obesity should be recognised as a disease


The Society endorses this position statement on the recognition of obesity as a disease.

November 2014 Under review


Use of animals in medical research


The Society's position on the use of animals in medical research (original March 2010, reviewed April 2012, November 2014).

October 2012 (reviewed 2018)


Society for Endocrinology position statement on hypogonadism and ageing


The Society for Endocrinology’s Clinical Committee provides information on the diagnosis and treatment of hypogonadism in ageing men. A patient factsheet to accompany this position statement can be found on the Society’s public-facing website You & Your Hormones.

November 2011 Under review


Dopamine Agonists
Society for Endocrinology position statement on the use of dopamine agonists in endocrine disorders


This statement (originally issued in February 2009 and reviewed November 2011) was issued in response to information contained in the MHRA Drug Safety Update (Volume 2, Issue 3 October 2008).

October 2011  Under review


Specialist Endocrinology Services
Society for Endocrinology’s information on specialist endocrinology services


This document (originally issued in July 2009 and recently reviewed) explains how the wide range of endocrine conditions are best diagnosed and managed by teams of doctors working in a variety of different clinical settings.

September 2011 (reviewed 2018)


Use of synthetic ACTH (Synacthen) in patients with a history of asthma


This statement advises on the use of Synacthen in patients with a history of asthma.

September 2015
(to be reviewed 2019)


Management of primary hypothyroidism. (The statement is available on the BTA website)


The Society endorses these guidelines, written by the British Thyroid Association in 2015, for the management of primary hypothyroidism.

July 2011 (reviewed 2018)


Inhaled Steroids
Endocrine effects of inhaled steroids in respiratory disease


This position statement highlights the suppressive effects of inhaled corticosteroids on the endogenous hypothalamo-pituitary-adrenal axis.

October 2010 (reviewed 2017)


Phaeochromocytoma and paraganglioma
Perioperative Preparation of Patients with Phaeochromocytoma /Paraganglioma (PPGL)


This statement outlines key points in the perioperative management of patients with PPGL.